Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.

ABSTRACT:

SUBMITTER: Stephenson KE 

PROVIDER: S-EPMC7472641 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature